- Home
- CUE vs BGSF Comparison
CUE vs BGSF Comparison
Compare CUE & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- BGSF
- Stock Information
- Founded
- CUE 2014
- BGSF 2007
- Country
- CUE United States
- BGSF United States
- Employees
- CUE N/A
- BGSF N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- BGSF Professional Services
- Sector
- CUE Health Care
- BGSF Consumer Discretionary
- Exchange
- CUE Nasdaq
- BGSF Nasdaq
- Market Cap
- CUE 59.5M
- BGSF 70.1M
- IPO Year
- CUE 2018
- BGSF N/A
- Fundamental
- Price
- CUE $0.74
- BGSF $7.71
- Analyst Decision
- CUE Strong Buy
- BGSF Strong Buy
- Analyst Count
- CUE 2
- BGSF 1
- Target Price
- CUE $3.00
- BGSF $9.00
- AVG Volume (30 Days)
- CUE 116.9K
- BGSF 319.7K
- Earning Date
- CUE 08-12-2025
- BGSF 11-05-2025
- Dividend Yield
- CUE N/A
- BGSF N/A
- EPS Growth
- CUE N/A
- BGSF N/A
- EPS
- CUE N/A
- BGSF N/A
- Revenue
- CUE $8,286,000.00
- BGSF $266,615,000.00
- Revenue This Year
- CUE N/A
- BGSF N/A
- Revenue Next Year
- CUE $10.19
- BGSF N/A
- P/E Ratio
- CUE N/A
- BGSF N/A
- Revenue Growth
- CUE N/A
- BGSF 28.60
- 52 Week Low
- CUE $0.45
- BGSF $2.91
- 52 Week High
- CUE $1.99
- BGSF $9.06
- Technical
- Relative Strength Index (RSI)
- CUE 38.09
- BGSF 77.49
- Support Level
- CUE $0.77
- BGSF $6.36
- Resistance Level
- CUE $0.79
- BGSF $6.30
- Average True Range (ATR)
- CUE 0.04
- BGSF 0.28
- MACD
- CUE -0.01
- BGSF 0.14
- Stochastic Oscillator
- CUE 12.87
- BGSF 81.01
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.